Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Association of Adverse Drug Events with Broad-spectrum Antibiotic Use in Hospitalized Patients: A Single-center Study.

Hagiya H, Kokado R, Ueda A, Okuno H, Morii D, Hamaguchi S, Yamamoto N, Yoshida H, Tomono K.

Intern Med. 2019 May 22. doi: 10.2169/internalmedicine.2603-18. [Epub ahead of print]

2.

Antibiotic-associated adverse drug events at a Japanese academic hospital.

Kokado R, Hagiya H, Koyama T, Matsui E, Okuno H, Morii D, Hamaguchi S, Yoshida H, Miwa Y, Tomono K.

J Infect Chemother. 2019 May;25(5):392-395. doi: 10.1016/j.jiac.2018.11.002. Epub 2018 Nov 27.

PMID:
30497807
3.

Association of Adverse Events With Antibiotic Use in Hospitalized Patients.

Tamma PD, Avdic E, Li DX, Dzintars K, Cosgrove SE.

JAMA Intern Med. 2017 Sep 1;177(9):1308-1315. doi: 10.1001/jamainternmed.2017.1938.

4.

The use of broad-spectrum antibiotics reduces the incidence of surgical site infection after pancreatoduodenectomy.

Tanaka K, Nakamura T, Imai S, Kushiya H, Miyasaka D, Nakanishi Y, Asano T, Noji T, Tsuchikawa T, Okamura K, Shichinohe T, Hirano S.

Surg Today. 2018 Sep;48(9):825-834. doi: 10.1007/s00595-018-1658-3. Epub 2018 Apr 23.

PMID:
29687153
5.

Comparison of the Nephrotoxicity of Vancomycin in Combination With Cefepime, Meropenem, or Piperacillin/Tazobactam: A Prospective, Multicenter Study.

Mullins BP, Kramer CJ, Bartel BJ, Catlin JS, Gilder RE.

Ann Pharmacother. 2018 Jul;52(7):639-644. doi: 10.1177/1060028018757497. Epub 2018 Feb 14.

PMID:
29442542
6.

Retrospective evaluation of piperacillin-tazobactam, imipenem-cilastatin and meropenem used on surgical floors at a tertiary care hospital in Saudi Arabia.

Youssif E, Aseeri M, Khoshhal S.

J Infect Public Health. 2018 Jul - Aug;11(4):486-490. doi: 10.1016/j.jiph.2017.09.001. Epub 2017 Nov 15.

7.

[Concentration of tazobactam/piperacillin in the cerebrospinal fluid of patients with Haemophilus influenzae type B meningitis].

Fukasawa C, Hoshino T, Kutsuna S, Sawada K, Sato H, Ishiwada N.

Kansenshogaku Zasshi. 2013 Sep;87(5):590-5. Japanese.

PMID:
24195168
8.

Doripenem monohydrate, a broad-spectrum carbapenem antibiotic.

Matthews SJ, Lancaster JW.

Clin Ther. 2009 Jan;31(1):42-63. doi: 10.1016/j.clinthera.2009.01.013. Review.

PMID:
19243706
9.

Evaluation of antimicrobial stewardship (AS) for appropriate use of antimicrobial agents.

Matsuoka T, Kato M, Shinoda Y, Ohashi K, Yoshida S, Mori T, Tachi T, Yoshimura T, Teramachi H.

Pharmazie. 2017 May 1;72(5):296-299. doi: 10.1691/ph.2017.6968.

PMID:
29441876
10.

[Basic and clinical studies on tazobactam/piperacillin in pediatric field].

Motohiro T, Nagai K, Yamada T, Oki S, Yamada T, Yoshinaga Y, Tsumura N, Oda K, Sakata Y, Kato H, Imai S, Morita J, Matsuo Y, Ikezawa S, Takahgashi K, Fukuda T, Yamashita Y, Aramaki M, Hayashi M, Yamakawa R, Ono-E, Tananari Y, Tsutsumi T, Hoshuyama A, Aida K, et al.

Jpn J Antibiot. 1998 Jun;51(6):413-31. Japanese.

PMID:
9755831
12.

[A comparative study of tazobactam/piperacillin and piperacillin in chronic respiratory tract infections].

Oizumi K, Kawahara M, Kawaguchi S, Sigematsu H, Tanaka F, Sano N, Saito A, Hiraga Y, Ohmichi M, Inoue H, et al.

Jpn J Antibiot. 1995 Apr;48(4):482-513. Japanese.

PMID:
7783314
13.

[In vitro synergistic effects of tazobactam/piperacillin with various antibiotics].

Nishida K, Niidome K, Hashimoto M, Otsuki M, Nishino T.

Jpn J Antibiot. 1994 Oct;47(10):1348-62. Japanese.

PMID:
7807695
14.

[Clinical effects of piperacillin and tazobactam/piperacillin on Haemophilus influenzae lower respiratory tract infection in pediatric patients].

Sudo F, Ishiwada N, Hoshino T, Fukasawa C, Inami Y, Hishiki H, Takeda N, Kurosaki T, Kohno Y.

Kansenshogaku Zasshi. 2005 Sep;79(9):637-43. Japanese.

PMID:
16248372
15.

A retrospective analysis of adverse events among patients receiving daptomycin versus vancomycin during outpatient parenteral antimicrobial therapy.

Schrank GM, Wright SB, Branch-Elliman W, LaSalvia MT.

Infect Control Hosp Epidemiol. 2018 Aug;39(8):947-954. doi: 10.1017/ice.2018.107. Epub 2018 Jun 12.

PMID:
29893658
16.

[A comparative study of tazobactam/piperacillin and piperacillin in bacterial pneumonia].

Oizumi K, Ohno T, Kawahara M, Kawaguchi S, Saisho M, Mitutake Y, Saito A, Tomizawa M, Koike T, Takebe K, et al.

Jpn J Antibiot. 1995 Apr;48(4):449-81. Japanese.

PMID:
7783313
17.

[Antibiotics--TAZ/PIPC, synercid, linezolid, everninomicin].

Hidai H.

Nihon Rinsho. 2001 Apr;59(4):785-9. Review. Japanese.

PMID:
11305007
18.
19.

[Pharmacokinetic, bacteriological and clinical evaluation of tazobactam/piperacillin in pediatrics].

Iwai N, Nakamura H, Miyazu M.

Jpn J Antibiot. 1998 May;51(5):346-61. Japanese.

PMID:
9693967
20.

Prospective randomized comparison study of piperacillin/tazobactam and meropenem for healthcare-associated pneumonia in Japan.

Yamamoto Y, Izumikawa K, Morinaga Y, Nakamura S, Kurihara S, Imamura Y, Miyazaki T, Tsukamoto M, Kakeya H, Yanagihara K, Yasuoka A, Kohno S.

J Infect Chemother. 2013 Apr;19(2):291-8. doi: 10.1007/s10156-013-0552-6. Epub 2013 Jan 24.

PMID:
23345050

Supplemental Content

Support Center